Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome

International Journal of Cardiology

Volumn 126, Issue 2, 2008, Pages 196-203

  Jiménez Candil, Javier ^a   Cruz González, Ignacio ^a   Martín, Francisco ^a   Pabón, Pedro ^a   León, Víctor ^a   Hernández, Jesús ^a   Sánchez Flores, Manuel ^a   Moríñigo, José ^a   Ledesma, Claudio ^a   Martín Luengo, Cándido ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Cardiovascular death; Myocardial infarction; QRS duration; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RISK ASSESSMENT; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART FUNCTION TESTS; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 42649083319     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.03.129     Document Type: Article

References (20)

1. Iuliano S., Fisher S.G., Karasik P.E., Fletcher R.D., and Singh S.N. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 6 (2002) 1085-1091
2. Bruch C., Gotzmann M., Stypmann J., et al. Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol 45 7 (2005) 1072-1075
3. Hathaway W.R., Peterson E.D., Wagner G.S., et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I investigators. Global utilization of streptokinase and t-PA for occluded coronary arteries. JAMA 279 5 (1998) 387-391
4. Bauer A., Watanabe M.A., Barthel P., Schneider R., Ulm K., and Schmidt G. QRS duration and late mortality in unselected post-infarction patients of the revascularization era. Eur Heart J 27 4 (2006) 427-433
5. Yerra L., Anavekar N., Skali H., et al. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm 3 3 (2006) 313-316
6. Brilakis E.S., Mavrogiorgos N.C., Kopecky S.L., et al. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol 89 9 (2002) 1013-1018
7. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 23 (2002) 1809-1840
8. Cleland J.G., Erhardt L., Hall A.S., Winter C., and Ball S.G. Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) study investigators. J Cardiovasc Pharmacol 22 Suppl 9 (1993) S22-S27
9. Braunwald E., Antman E., Beasley J., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
10. Oikarinen L., Nieminen M.S., Viitasalo M., et al. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension study. Hypertension 43 5 (2004) 1029-1034
11. Sweeney M.O., Hellkamp A.S., Lee K.L., and Lamas G.A. Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 111 19 (2005) 2418-2423
12. Desai A.D., Yaw T.S., Yamazaki T., Kaykha A., Chun S., and Froelicher V.F. Prognostic significance of quantitative QRS duration. Am J Med 119 7 (2006) 600-606
13. Elhendy A., Hammill S.C., Mahoney D.W., and Pellikka P.A. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 96 8 (2005) 1082-1088
14. Michaelides A.P., Aigyprladou M.N., Andrikopoulos G.K., et al. The prognostic value of a QRS score during exercise testing. Clin Cardiol 28 8 (2005) 375-380
15. Mazzoleni A., Curtin M.E., Wolff R., Reiner L., and Somes G. On the relationship between heart weights, fibrosis, and QRS duration. J Electrocardiol 8 3 (1975) 233-236
16. Yamada T., Fukunami M., Ohmori M., et al. New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: use of signal-averaged electrocardiography. Am Heart J 126 3 Pt 1 (1993) 626-631
17. Sheridan D.J., Culling W., and Penny W.J. Electrophysiological disturbances associated with acute myocardial infarction. Eur Heart J 7 Suppl B (1986) 11-18
18. Korhonen P., Husa T., Tierala I., et al. QRS duration in high-resolution methods and standard ECG in risk assessment after first and recurrent myocardial infarctions. Pacing Clin Electrophysiol 29 8 (2006) 830-836
19. Rouleau F., Merheb M., Geffroy S., et al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 24 10 (2001) 1500-1506
20. Yu C.M., Lin H., Zhang Q., and Sanderson J.E. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89 1 (2003) 54-60